Shivaji UN, Nardone OM, Cannatelli R, Smith SC, Ghosh S, Iacucci M. Small molecule oral focused therapies in ulcerative colitis. Lancet Gastroenterol. 2020;5:850–61.
Prados ME, Garcia-Martin A, Unciti-Broceta JD, Palomares B, Collado JA, Minassi A, et al. Betulinic acid hydroxamate prevents colonic irritation and fibrosis in murine fashions of inflammatory bowel illness. Acta Pharmacol Sin. 2021;42:1124–38.
Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6:74.
Chung CH, Jung W, Keum H, Kim TW, Jon S. Nanoparticles derived from the pure antioxidant rosmarinic acid ameliorate acute inflammatory bowel illness. ACS Nano. 2020;14:6887–96.
Neurath MF. Cytokines in inflammatory bowel illness. Nat Rev Immunol. 2014;14:329–42.
Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal irritation and backbone: a possible therapeutic goal in IBD. Nat Rev Gastro Hepat. 2019;16:531–43.
Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in persistent irritation. Nat Rev Immunol. 2017;17:248–61.
Zhang S, Langer R, Traverso G. Nanoparticulate drug supply techniques concentrating on irritation for remedy of inflammatory bowel illness. Nano At the moment. 2017;16:82–96.
Zhang S, Ermann J, Succi MD, Zhou A, Hamilton MJ, Cao BN, et al. An inflammation-targeting hydrogel for native drug supply in inflammatory bowel illness. Sci Transl Med. 2015;7:300ra128.
Torres J, Danese S, Colombel JF. New therapeutic avenues in ulcerative colitis: considering out of the field. Intestine. 2013;62:1642–52.
Yang C, Merlin D. Nanoparticle-mediated drug supply techniques for the remedy of IBD: present views. Int J Nanomed. 2019;14:8875–89.
Yang M, Zhang Y, Ma Y, Yan X, Gong L, Zhang M, et al. Nanoparticle-based therapeutics of inflammatory bowel illnesses: a story overview of the present state and prospects. J Bio-X Res. 2020;3:157–73.
Zeng Z, He X, Li C, Lin S, Chen H, Liu L, et al. Oral supply of antioxidant enzymes for efficient remedy of inflammatory illness. Biomaterials. 2021;271: 120753.
Han W, Xie B, Li Y, Shi L, Wan J, Chen X, et al. Orally deliverable nanotherapeutics for the synergistic remedy of colitis-associated colorectal most cancers. Theranostics. 2019;9:7458–73.
Zhang M, Xu C, Liu D, Han M, Wang L, Merlin D. Oral supply of nanoparticles loaded with ginger energetic compound, 6-shogaol, attenuates ulcerative colitis and promotes wound therapeutic in a murine mannequin of ulcerative colitis. J Crohns Colitis. 2018;12:217–29.
Li C, Li L, Chen S, Zhang J, Lu W. Antioxidant nanotherapies for the remedy of inflammatory illnesses. Entrance Bioeng Biotech. 2020;8:200.
Liu Y, Cheng Y, Zhang H, Zhou M, Yu Y, Lin S, et al. Built-in cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory remedy. Sci Adv. 2020;6:eabb2695.
Ren Q, Solar S, Zhang X. Redox-active nanoparticles for inflammatory bowel illness. Nano Res. 2021;14:2535–57.
Yang M, Zhang F, Yang C, Wang L, Sung J, Garg P, et al. Oral focused supply by nanoparticles enhances efficacy of an Hsp90 inhibitor by lowering systemic publicity in murine fashions of colitis and colitis-associated most cancers. J Crohns Colitis. 2020;14:130–41.
Li C, Zhao Y, Cheng J, Guo J, Zhang Q, Zhang X, et al. A Proresolving peptide nanotherapy for site-specific remedy of inflammatory bowel illness by regulating proinflammatory microenvironment and intestine microbiota. Adv Sci. 2019;6:1900610.
Zhang M, Xu C, Wen L, Han M, Xiao B, Zhou J, et al. A hyaluronidase-responsive nanoparticle-based drug supply system for concentrating on colon most cancers cells. Most cancers Res. 2016;76:7208–18.
Liang C, Bai X, Qi C, Solar Q, Han X, Lan T, et al. Π electron-stabilized polymeric micelles potentiate docetaxel remedy in advanced-stage gastrointestinal most cancers. Biomaterials. 2021;266: 120432.
Shi H, Zhao X, Gao J, Liu Z, Liu Z, Wang Ok, et al. Acid-resistant ROS-responsive hyperbranched polythioether micelles for ulcerative colitis remedy. Chin Chem Lett. 2020;31:3102–6.
Liu P, Gao C, Chen H, Vong CT, Wu X, Tang X, et al. Receptor-mediated focused drug supply techniques for remedy of inflammatory bowel illness: alternatives and rising methods. Acta Pharm Sin B. 2020;11(9):2798–818.
Lei C, Mu J, Teng Y, He L, Xu F, Zhang X, et al. Lemon exosome-like nanoparticles-manipulated probiotics defend mice from C. diff an infection. Iscience. 2020;23:101571.
Hu Q, Lyon CJ, Fletcher JK, Tang W, Wan M, Hu TY. Extracellular vesicle actions regulating macrophage-and tissue-mediated harm and restore responses. Acta Pharm Sin B. 2021;11:1493–512.
Perut F, Roncuzzi L, Avnet S, Massa A, Zini N, Sabbadini S, et al. Strawberry-derived exosome-like nanoparticles stop oxidative stress in human mesenchymal stromal cells. Biomolecules. 2021;11:87.
Yang C, Zhang M, Merlin D. Advances in plant-derived edible nanoparticle-based lipid nano-drug supply techniques as therapeutic nanomedicines. J Mater Chem B. 2018;6:1312–21.
Sreedhar R, Arumugam S, Thandavarayan RA, Karuppagounder V, Watanabe Ok. Curcumin as a therapeutic agent within the chemoprevention of inflammatory bowel illness. Drug Discov At the moment. 2016;21:843–9.
He Y, Yue Y, Zheng X, Zhang Ok, Chen S, Du Z. Curcumin, irritation, and persistent illnesses: how are they linked? Molecules. 2015;20:9183–213.
Vecchi Brumatti L, Marcuzzi A, Tricarico PM, Zanin V, Girardelli M, Bianco AM. Curcumin and inflammatory bowel illness: potential and limits of progressive therapies. Molecules. 2014;19:21127–53.
Aggarwal BB, Shishodia S. Molecular targets of dietary brokers for prevention and remedy of most cancers. Biochem Pharmacol. 2006;71:1397–421.
Hsiang CY, Lo HY, Huang HC, Li CC, Wu SL, Ho TY. Ginger extract and zingerone ameliorated trinitrobenzene sulphonic acid-induced colitis in mice through modulation of nuclear factor-κB exercise and interleukin-1β signalling pathway. Meals Chem. 2013;136:170–7.
Maiti P, Dunbar GL. Use of Curcumin, a pure polyphenol for concentrating on molecular pathways in treating age-related neurodegenerative illnesses. Int J Mol Sci. 2018;19:1637.
Abo-Zaid MA, Shaheen ES, Ismail AH. Immunomodulatory impact of curcumin on hepatic cirrhosis in experimental rats. J Meals Biochem. 2020;44: e13219.
Memarzia A, Khazdair MR, Behrouz S, Gholamnezhad Z, Jafarnezhad M, Saadat S, et al. Experimental and medical stories on anti-inflammatory, antioxidant, and immunomodulatory results of Curcuma longa and curcumin, an up to date and complete overview. BioFactors. 2021;47(3):311–50.
Moura FA, de Andrade KQ, Dos Santos JC, Araújo OR, Goulart MO. Antioxidant remedy for remedy of inflammatory bowel illness: does it work? Redox Biol. 2015;6:617–39.
Zhang M, Viennois E, Xu C, Merlin D. Plant derived edible nanoparticles as a brand new therapeutic strategy towards illnesses. Tissue Limitations. 2016;4: e1134415.
Mu J, Zhuang X, Wang Q, Jiang H, Deng Z, Wang B, et al. Interspecies communication between plant and mouse intestine host cells by means of edible plant derived exosome-like nanoparticles. Mol Nutr Meals Res. 2014;58:1561–73.
Deng Z, Rong Y, Teng Y, Mu J, Zhuang X, Tseng M, et al. Broccoli-derived nanoparticle inhibits mouse colitis by activating dendritic cell AMP-activated protein kinase. Mol Ther. 2017;25:1641–54.
Teng Y, Ren Y, Sayed M, Hu X, Lei C, Kumar A, et al. Plant-derived exosomal microRNAs form the intestine microbiota. Cell Host Microbe. 2018;24:637–52.
Zhuang X, Deng Z, Mu J, Zhang L, Yan J, Miller D, et al. Ginger-derived nanoparticles defend towards alcohol-induced liver injury. J Extracell Vesicles. 2015;4:28713.
Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, et al. Edible ginger-derived nanoparticles: a novel therapeutic strategy for the prevention and remedy of inflammatory bowel illness and colitis-associated most cancers. Biomaterials. 2016;101:321–40.
Sung J, Yang C, Viennois E, Zhang M, Merlin D. Isolation, purification, and characterization of ginger-derived nanoparticles (GDNPs) from ginger, rhizome of Zingiber officinale. Bio-Protoc. 2019;9: e3390.
Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: common methodologies and newest developments. BioMed Res Int. 2018;2018:8545347.
Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, et al. Standardization of pattern assortment, isolation and evaluation strategies in extracellular vesicle analysis. J Extracell Vesicles. 2013;2:20360.
Jones N, Blagih J, Zani F, Rees A, Hill DG, Jenkins BJ, et al. Fructose reprogrammes glutamine-dependent oxidative metabolism to help LPS-induced irritation. Nat Commun. 2021;12:1–13.
Linghu KG, Ma Q, Zhao G, Xiong W, Lin L, Zhang Q, et al. Leocarpinolide B attenuates LPS-induced irritation on RAW264.7 macrophages by mediating NF-κB and Nrf2 pathways. Eur J Pharmacol. 2020;868:172854.
Li S, Xie A, Li H, Zou X, Zhang Q. A self-assembled, ROS-responsive Janus-prodrug for focused remedy of inflammatory bowel illness. J Management Launch. 2019;316:66–78.
Xu J, Zhang Y, Xu J, Wang M, Liu G, Wang J, et al. Reversing tumor stemness through orally focused nanoparticles achieves environment friendly colon most cancers remedy. Biomaterials. 2019;216: 119247.
Fasolino I, Izzo AA, Clavel T, Romano B, Haller D, Borrelli F. Orally administered allyl sulfides from garlic ameliorate murine colitis. Mol Nutr Meals Res. 2015;59:434–42.
Wu C, Wu Y, Jin Y, Zhu P, Shi W, Li J, et al. Endosomal/lysosomal location of organically modified silica nanoparticles following caveolae-mediated endocytosis. RSC Adv. 2019;9:13855–62.
Zhang Y, Commisso C. Macropinocytosis in most cancers: a fancy signaling community. Developments Most cancers. 2019;5:332–4.
Kim SH, Cho SN, Lim YJ, Choi JA, Lee J, Go D, et al. Phagocytosis influences the intracellular survival of Mycobacterium smegmatis through the endoplasmic reticulum stress response. Cell Biosci. 2018;8:1–11.
Oh JM, Choi SJ, Kim ST, Choy JH. Mobile uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy on account of clathrin-mediated endocytosis. Bioconjugate Chem. 2006;17:1411–7.
Zhao H, Cheng N, Zhou W, Chen S, Wang Q, Gao H, et al. Honey polyphenols ameliorate DSS-induced ulcerative colitis through modulating intestine microbiota in rats. Mol Nutr Meals Res. 2019;63:1900638.
Yang C, Zhang M, Lama S, Wang L, Merlin D. Pure-lipid nanoparticle-based therapeutic strategy to ship 6-shogaol and its metabolites M2 and M13 to the colon to deal with ulcerative colitis. J Management Launch. 2020;323:293–310.
Xu X, An H, Zhang D, Tao H, Dou Y, Li X, et al. A self-illuminating nanoparticle for irritation imaging and most cancers remedy. Sci Adv. 2019;5:eaat2953.
Li H, Feng C, Fan C, Yang Y, Yang X, Lu H, et al. Intervention of oncostatin M-driven mucosal irritation by berberine exerts therapeutic property in persistent ulcerative colitis. Cell Demise Dis. 2020;11:271.
Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious illnesses. Entrance Immunol. 2014;5:491.
Yan Y, Shao M, Qi Q, Xu Y, Yang X, Zhu F, et al. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis through suppressing neutrophils and macrophages. Acta Pharmacol Sin. 2018;39:1633–44.
Kim YJ, Kim EH, Hahm KB. Oxidative stress in inflammation-based gastrointestinal tract illnesses: challenges and alternatives. J Gastroen Hepatol. 2012;27:1004–10.
Dickinson BC, Chang CJ. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol. 2011;7:504.
Campbell NK, Fitzgerald HK, Dunne A. Regulation of irritation by the antioxidant haem oxygenase 1. Nat Rev Immunol. 2021;21:1–15.
Waza AA, Hamid Z, Ali S, Bhat SA, Bhat MA. A overview on heme oxygenase-1 induction: is it a vital evil. Inflamm Res. 2018;67:579–88.
Daulagala AC, Bridges MC, Kourtidis A. E-cadherin past construction: a signaling hub in colon homeostasis and illness. Int J Mol Sci. 2019;20:2756.
Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of intestinal barrier perform by microbial metabolites. Cell Mol Gastroenter. 2021;11:1463–82.
Terciolo C, Dobric A, Ouaissi M, Siret C, Breuzard G, Silvy F, et al. Saccharomyces boulardii CNCM I-745 restores intestinal barrier integrity by regulation of E-cadherin recycling. J Crohns Colitis. 2017;11:999–1010.
Cavallini F, Tarantola M. ECIS based mostly wounding and reorganization of cardiomyocytes and fibroblasts in co-cultures. Prog Biophys Mol Bio. 2019;144:116–27.
Merlin-Zhang O, Sung J, Viennois E. In vitro intestinal epithelial wound-healing assays utilizing Electrical Cell-Substrate Impedance Sensing Instrument. Bio-Protoc. 2019;9: e3351.
Bronte V, Pittet MJ. The spleen in native and systemic regulation of immunity. Immunity. 2013;39:806–18.
Wang S, Liu X, Wang Y, Xu D, Liang C, Guo J, et al. Biocompatibility of synthetic micro/nanomotors to be used in biomedicine. Nanoscale. 2019;11:14099–112.
Williams DF. On the mechanisms of biocompatibility. Biomaterials. 2008;29:2941–53.
Kou J, Wang M, Shi J, Zhang H, Pu X, Tune S, et al. Curcumin reduces cognitive deficits by inhibiting neuroinflammation by means of the endoplasmic reticulum stress pathway in apolipoprotein E4 transgenic mice. ACS Omega. 2021;6:6654–62.
Buhrmann C, Mobasheri A, Busch F, Aldinger C, Stahlmann R, Montaseri A, et al. Curcumin modulates nuclear factor-κB (nf-κB)-mediated irritation in human tenocytes in vitro: position of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 2011;286:28556–66.
Viennois E, Xiao B, Ayyadurai S, Wang L, Wang P, Zhang Q, et al. Micheliolide, a brand new sesquiterpene lactone that inhibits intestinal irritation and colitis-associated most cancers. Lab Investig. 2014;94:950–65.
Lee SH, Bajracharya R, Min JY, Han JW, Park BJ, Han HK. Strategic approaches for colon focused drug supply: an outline of latest developments. Pharmaceutics. 2020;12:68.
Zhang M, Merlin D. Nanoparticle-based oral drug supply techniques concentrating on the colon for remedy of ulcerative colitis. Inflamm Bowel Dis. 2018;24:1401–15.
Sundaram Ok, Miller DP, Kumar A, Teng Y, Sayed M, Mu J, et al. Plant-derived exosomal nanoparticles inhibit pathogenicity of Porphyromonas gingivalis. Iscience. 2019;21:308–27.
Tirosh B, Khatib N, Barenholz Y, Nissan A, Rubinstein A. Transferrin as a luminal goal for negatively charged liposomes within the infected colonic mucosa. Mol Pharmaceut. 2009;6:1083–91.
Ehehalt R, Wagenblast J, Erben G, Lehmann WD, Hinz U, Merle U, et al. Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis sufferers. A quantitative strategy by nanoelectrospray-tandem mass spectrometry. Scand J Gastroenterol. 2004;39:737–42.
Ju S, Mu J, Dokland T, Zhuang X, Wang Q, Jiang H, et al. Grape exosome-like nanoparticles induce intestinal stem cells and defend mice from DSS-induced colitis. Mol Ther. 2013;21:1345–57.
Zhuang X, Teng Y, Samykutty A, Mu J, Deng Z, Zhang L, et al. Grapefruit-derived nanovectors delivering therapeutic miR17 by means of an intranasal route inhibit mind tumor development. Mol Ther. 2016;24:96–105.
Castanheira FV, Kubes P. Neutrophils and NETs in modulating acute and persistent irritation. Blood. 2019;133:2178–85.
Fullerton JN, Gilroy DW. Decision of irritation: a brand new therapeutic frontier. Nat Rev Drug Discov. 2016;15:551.